Lucid Diagnostics Inc
NASDAQ:LUCD
Intrinsic Value
The intrinsic value of one LUCD stock under the Base Case scenario is 2.07 USD. Compared to the current market price of 1.58 USD, Lucid Diagnostics Inc is Undervalued by 24%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Lucid Diagnostics Inc
Fundamental Analysis

Revenue & Expenses Breakdown
Lucid Diagnostics Inc
Balance Sheet Decomposition
Lucid Diagnostics Inc
Current Assets | 25.1m |
Cash & Short-Term Investments | 22.4m |
Receivables | 45k |
Other Current Assets | 2.7m |
Non-Current Assets | 5.6m |
PP&E | 3.7m |
Intangibles | 736k |
Other Non-Current Assets | 1.1m |
Free Cash Flow Analysis
Lucid Diagnostics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Lucid Diagnostics Inc
Revenue
|
4.3m
USD
|
Cost of Revenue
|
-7.1m
USD
|
Gross Profit
|
-2.8m
USD
|
Operating Expenses
|
-43.3m
USD
|
Operating Income
|
-46.1m
USD
|
Other Expenses
|
-7m
USD
|
Net Income
|
-53m
USD
|
LUCD Profitability Score
Profitability Due Diligence
Lucid Diagnostics Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Score
Lucid Diagnostics Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
LUCD Solvency Score
Solvency Due Diligence
Lucid Diagnostics Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Score
Lucid Diagnostics Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LUCD Price Targets Summary
Lucid Diagnostics Inc
According to Wall Street analysts, the average 1-year price target for LUCD is 4.08 USD with a low forecast of 2.02 USD and a high forecast of 7.35 USD.
Dividends
Current shareholder yield for LUCD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one LUCD stock under the Base Case scenario is 2.07 USD.
Compared to the current market price of 1.58 USD, Lucid Diagnostics Inc is Undervalued by 24%.